Keith Katkin - 10 Jan 2025 Form 4 Insider Report for Eledon Pharmaceuticals, Inc. (ELDN)

Role
Director
Signature
/s/ Paul Little, as attorney-in-fact for Keith Katkin
Issuer symbol
ELDN
Transactions as of
10 Jan 2025
Net transactions value
$0
Form type
4
Filing time
13 Jan 2025, 17:30:07 UTC
Previous filing
28 May 2024
Next filing
07 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELDN Stock Option (right to buy) Award $0 +77,175 $0.000000 77,175 10 Jan 2025 Common Stock 77,175 $4.04 Direct F1
transaction ELDN Restricted Stock Units Award $0 +8,575 $0.000000 8,575 10 Jan 2025 Common Stock 8,575 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase up to 77,175 shares of common stock, which option vests with respect to 100% of the total number of shares on January 10, 2026.
F2 Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration.
F3 100% of the restricted stock units will vest on January 10, 2026.